Table 1.
Parameters | ERAS Group (n = 64) | Control Group (n = 65) |
P | |||
---|---|---|---|---|---|---|
Age (years) | 0.723 | |||||
<40 | patients, n (%) | 38 | 59.4% | 36 | 55.4% | |
40-65 | patients, n (%) | 26 | 40.6% | 29 | 44.6% | |
Gender | 0.713 | |||||
Male | patients, n (%) | 21 | 32.8% | 24 | 36.9% | |
Female | patients, n (%) | 43 | 67.2% | 41 | 63.1% | |
BMI (kg/m2) | Median BMI, kg/m2 (Range) | 24.1 | 15.9-29.6 | 24.7 | 19.1-28.4 | 0.395 |
ASA classification | 0.358 | |||||
ASA I | n (%) | 9 | 14.1% | 14 | 21.5% | |
ASA II | n (%) | 55 | 85.9% | 51 | 78.5% | |
Concomitant diseases | ||||||
Cardiac/hypertension | n (%) | 13 | 18.8% | 12 | 15.4% | 0.827 |
Smoker | n (%) | 6 | 10.9% | 8 | 15.4% | 0.778 |
Liver/gall bladder | n (%) | 7 | 10.9% | 4 | 7.7% | 0.364 |
Lung | n (%) | 5 | 7.8% | 7 | 10.8% | 0.763 |
Diabetes mellitus | n (%) | 11 | 6.3% | 7 | 7.7% | 0.321 |
Miscellaneous | n (%) | 13 | 4.7% | 6 | 6.2% | 0.087 |
Indication for surgery | Meningioma, n (%) | 38 | 59.4% | 30 | 46.2% | 0.516 |
Vestibular schwannoma, n (%) | 7 | 10.9% | 9 | 13.8% | ||
CPA Cholesteatoma, n (%) | 6 | 9.4% | 8 | 12.3% | ||
Glioma, n (%) | 13 | 20.3% | 18 | 27.7% | ||
Lesion location | 0.566 | |||||
Supratentorial superficial | 19 | 29.7% | 16 | 24.6% | ||
Supratentorial deep | 23 | 35.9% | 20 | 30.8% | ||
Infratentorial | 22 | 34.4% | 28 | 43.1% |
ASA: American Society of Anesthesiologists.
CPA: cerebellopontine angle.